1. Date of resolution: 2026/05/25. 2. Directors permitted: Hsu Chieh-li, Ke Chang-chi, Ho Mei-yueh, Chen Hsin-tso, Wu Tsung-fan, Chiu Tai-san, Hu Ching-ying. 3. Scope: Acting as directors or managers in businesses similar to the company. 4. Period: During their tenure. 5. Resolution: Approved under Article 209 of the Company Act. 6. Mainland China business: Ke Chang-chi serves as a supervisor at Beijing Xindong Lianchuang Biotechnology Co., Ltd. 7. Financial impact: None.

FACT BOX

  • Source: PR Times
  • Category: Corporate Governance